Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
41.34
-0.92 (-2.18%)
Feb 21, 2025, 4:00 PM EST - Market closed
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $7.64 billion as of February 21, 2025. Its market cap has increased by 55.57% in one year.
Market Cap
7.64B
Enterprise Value
6.18B
1-Year Change
55.57%
Ranking
Category
Stock Price
$41.34
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $7.64B, an increase of 364.55%. That is a compound annual growth rate of 35.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 7.64B | -5.49% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 800.25B |
| UnitedHealth Group | 421.43B |
| Johnson & Johnson | 389.52B |
| Novo Nordisk | 370.84B |
| AbbVie | 357.45B |
| Abbott Laboratories | 234.32B |
| AstraZeneca | 227.07B |
| Merck & Co. | 225.19B |